NCT06705569View on ClinicalTrials.gov

A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

April 4, 2025

Study Completion Date

April 4, 2025

Conditions
Healthy
Interventions
DRUG

Tafamidis 61 mg free acid tablet (Test)

Tafamidis 61 mg free acid tablet (Test)

DRUG

Tafamidis 61 mg free acid capsule (Reference)

Tafamidis 61 mg free acid capsule (Reference)

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY